INTERNATIONAL BRAIN TUMOUR ALLIANCE -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.687.400 0 1
2017 0 3.836.772 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CARTHERA2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GENEXPLAIN2
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
MIMETAS BV2
ROYAL COLLEGE OF SURGEONS IN IRELAND2
UNIVERSITE DU LUXEMBOURG2
AGILENT TECHNOLOGIES BELGIUM NV1
ARJUNA THERAPEUTICS SL1
BAYER1
BMS FRANCE1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CHAMPIONS ONCOLOGY INC1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSILICO BIOTECHNOLOGY1
IRISH CLINICAL ONCOLOGY RESEARCH GROUP LIMITED LBG1
LABORATOIRE NATIONAL DE SANTE1
LUXEMBOURG INSTITUTE OF HEALTH1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MILTENYI BIOTEC BV & CO KG1
ONCURIOUS NV1
OSLO UNIVERSITETSSYKEHUS HF1
PEPSCOPE BV1
RUPRECHT KARLS UNIVERSITAET HEIDELBERG1
SB SCIENCE MANAGEMENT UG1
SORBONNE UNIVERSITE1
TEVA PHARMACEUTICALS EUROPE BV1
THE BRIGHAM AND WOMEN'S HOSPITAL INC1
UNIVERSITAET STUTTGART1
VIB1
VIB VZW1
YUMAB1

Constancy:

Total number of partners: 42
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 42
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment GLIORESOLVEparticipant2.687.40021
2017-09-01Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics GLIOTRAINparticipant3.836.77223